Search Results - "Hutchinson, Sharon"

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy by Martin, Natasha K., Hickman, Matthew, Hutchinson, Sharon J., Goldberg, David J., Vickerman, Peter

“…Background. Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis…”
Get full text

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis by ASPINALL, Esther J, NAMBIAR, Dhanya, GOLDBERG, David J, HICKMAN, Matthew, WEIR, Amanda, VAN VELZEN, Eva, PALMATEER, Norah, DOYLE, Joseph S, HELLARD, Margaret E, HUTCHINSON, Sharon J

“…Needle and syringe programmes (NSP) aim to reduce the risk of HIV by providing people who inject drugs (PWID) with sterile injecting equipment. A recent review…”
Get full text

Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis by Aspinall, Esther J., Corson, Stephen, Doyle, Joseph S., Grebely, Jason, Hutchinson, Sharon J., Dore, Gregory J., Goldberg, David J., Hellard, Margaret E.

“…Background. Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain…”
Get full text

Effect of Vaccination on Transmission of SARS-CoV-2 by Shah, Anoop S.V, Gribben, Ciara, Bishop, Jennifer, Hanlon, Peter, Caldwell, David, Wood, Rachael, Reid, Martin, McMenamin, Jim, Goldberg, David, Stockton, Diane, Hutchinson, Sharon, Robertson, Chris, McKeigue, Paul M, Colhoun, Helen M, McAllister, David A

“…In this report from Scotland, vaccination of health care workers for SARS-CoV-2 was associated with a decrease in household transmission…”
Get full text

Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions by Palmateer, Norah E, Taylor, Avril, Goldberg, David J, Munro, Alison, Aitken, Celia, Shepherd, Samantha J, McAllister, Georgina, Gunson, Rory, Hutchinson, Sharon J

“…Government policy has precipitated recent changes in the provision of harm reduction interventions - injecting equipment provision (IEP) and opiate…”
Get full text

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals by Martin, Natasha K., Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J., Lima, Viviane D., Foster, Graham R., Dillon, John F., Goldberg, David J., Dore, Gregory J., Hickman, Matthew

“…Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as…”
Get full text

The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐study by Innes, Hamish, McAuley, Andrew, Alavi, Maryam, Valerio, Heather, Goldberg, David, Hutchinson, Sharon J.

“…In resource‐rich countries, chronic hepatitis C (CHC) infection is associated with a sizeable excess mortality risk. The extent to which this is due to (1) the…”
Get full text

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis by Fan, Rong, Papatheodoridis, George, Sun, Jian, Innes, Hamish, Toyoda, Hidenori, Xie, Qing, Mo, Shuyuan, Sypsa, Vana, Guha, Indra Neil, Kumada, Takashi, Niu, Junqi, Dalekos, George, Yasuda, Satoshi, Barnes, Eleanor, Lian, Jianqi, Suri, Vithika, Idilman, Ramazan, Barclay, Stephen T., Dou, Xiaoguang, Berg, Thomas, Hayes, Peter C., Flaherty, John F., Zhou, Yuanping, Zhang, Zhengang, Buti, Maria, Hutchinson, Sharon J., Guo, Yabing, Calleja, Jose Luis, Lin, Lanjia, Zhao, Longfeng, Chen, Yongpeng, Janssen, Harry L.A., Zhu, Chaonan, Shi, Lei, Tang, Xiaoping, Gaggar, Anuj, Wei, Lai, Jia, Jidong, Irving, William L., Johnson, Philip J., Lampertico, Pietro, Hou, Jinlin

“…Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a…”
Get full text

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation by Martin, Natasha K, Vickerman, Peter, Dore, Gregory J, Grebely, Jason, Miners, Alec, Cairns, John, Foster, Graham R, Hutchinson, Sharon J, Goldberg, David J, Martin, Thomas C.S, Ramsay, Mary, Hickman, Matthew

“…Graphical abstract…”
Get full text

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most? by Innes, Hamish, Goldberg, David, Dillon, John, Hutchinson, Sharon J

“…The expense of new therapies for HCV infection may force health systems to prioritise the treatment of certain patient groups over others. Our objective was to…”
Get more information

Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011-2020: A national retrospective cohort study by Fraser, Rosalyn, Yeung, Alan, Glancy, Megan, Hickman, Matthew, Jones, Hayley E, Priyadarshi, Saket, Horsburgh, Kirsten, Hutchinson, Sharon J, McAuley, Andrew

“…Opioid dependence is associated with an increased risk of suicide. Drug-related mortality among people with opioid dependence in Scotland has more than tripled…”
Get full text

A global investment framework for the elimination of hepatitis B by Howell, Jessica, Pedrana, Alisa, Schroeder, Sophia E., Scott, Nick, Aufegger, Lisa, Atun, Rifat, Baptista-Leite, Ricardo, Hirnschall, Gottfried, ‘t Hoen, Ellen, Hutchinson, Sharon J., Lazarus, Jeffrey V., Olufunmilayo, Lesi, Peck, Raquel, Sharma, Manik, Sohn, Annette H., Thompson, Alexander, Thursz, Mark, Wilson, David, Hellard, Margaret

“…More than 292 million people are living with hepatitis B worldwide and are at risk of death from cirrhosis and liver cancer. The World Health Organization…”
Get full text

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility by Martin, Natasha K, Vickerman, Peter, Foster, Graham R, Hutchinson, Sharon J, Goldberg, David J, Hickman, Matthew

“…Background & Aims Hepatitis C virus antiviral treatment is effective for individual patients but few active injecting drug users are treated. We considered the…”
Get full text

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study by McKeigue, Paul M, McAllister, David A, Hutchinson, Sharon J, Robertson, Chris, Stockton, Diane, Colhoun, Helen M

“…Reports have suggested that the efficacy of vaccines against COVID-19 might have fallen since the delta (B.1.617.2) SARS-CoV-2 variant replaced the alpha…”
Get full text

Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness by MacArthur, Georgina J, van Velzen, Eva, Palmateer, Norah, Kimber, Jo, Pharris, Anastasia, Hope, Vivian, Taylor, Avril, Roy, Kirsty, Aspinall, Esther, Goldberg, David, Rhodes, Tim, Hedrich, Dagmar, Salminen, Mika, Hickman, Matthew, Hutchinson, Sharon J

“…Abstract Background Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these…”
Get full text

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis by Stone, Jack, Fraser, Hannah, Lim, Aaron G, Walker, Josephine G, Ward, Zoe, MacGregor, Louis, Trickey, Adam, Abbott, Sam, Strathdee, Steffanie A, Abramovitz, Daniela, Maher, Lisa, Iversen, Jenny, Bruneau, Julie, Zang, Geng, Garfein, Richard S, Yen, Yung-Fen, Azim, Tasnim, Mehta, Shruti H, Milloy, Michael-John, Hellard, Margaret E, Sacks-Davis, Rachel, Dietze, Paul M, Aitken, Campbell, Aladashvili, Malvina, Tsertsvadze, Tengiz, Mravčík, Viktor, Alary, Michel, Roy, Elise, Smyrnov, Pavlo, Sazonova, Yana, Young, April M, Havens, Jennifer R, Hope, Vivian D, Desai, Monica, Heinsbroek, Ellen, Hutchinson, Sharon J, Palmateer, Norah E, McAuley, Andrew, Platt, Lucy, Martin, Natasha K, Altice, Frederick L, Hickman, Matthew, Vickerman, Peter

“…People who inject drugs (PWID) experience a high prevalence of incarceration and might be at high risk of HIV and hepatitis C virus (HCV) infection during or…”
Get full text

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data by Palayew, Adam, Stumo, Samya R, Cooke, Graham S, Hutchinson, Sharon J, Jauffret-Roustide, Marie, Maticic, Mojca, Harris, Magdalena, Metwally, Ammal M, Razavi, Homie, Lazarus, Jeffrey V

“…New hepatitis C virus (HCV) treatments spurred the World Health Organization (WHO) in 2016 to adopt a strategy to eliminate HCV as a public health threat by…”
Get full text

Drugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-Factors by White, Simon R, Bird, Sheila M, Merrall, Elizabeth L C, Hutchinson, Sharon J

“…We validate that the 28 days after hospital-discharge are high-risk for drugs-related death (DRD) among drug users in Scotland and investigate key risk-factors…”
Get full text

Meta-analysis of drug-related deaths soon after release from prison by Merrall, Elizabeth L. C., Kariminia, Azar, Binswanger, Ingrid A., Hobbs, Michael S., Farrell, Michael, Marsden, John, Hutchinson, Sharon J., Bird, Sheila M.

“…ABSTRACT Aims  The transition from prison back into the community is particularly hazardous for drug‐using offenders whose tolerance for heroin has been…”
Get full text

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations by Martin, Natasha K., Vickerman, Peter, Miners, Alec, Foster, Graham R., Hutchinson, Sharon J., Goldberg, David J., Hickman, Matthew

“…Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed countries. HCV antiviral treatment (peginterferon‐α + ribavirin)…”
Get full text